Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Fighting cancer relapse with remote activation of smart and targeted nanoconstructs

Project description

Targeted nanoconstructs for circulating tumour cells

Minimal residual disease (MRD) denotes the presence of a small number of cancer cells which remain after treatment and are responsible for cancer relapse. The detection and tackling of circulating tumour cells (CTCs) is technologically challenging with existing means. XtraUS, an EU-funded initiative, aims to develop a breakthrough technology to fight CTCs. The technology is based on a nanoconstruct that responds to certain stimuli and specifically targets CTCs without affecting haematopoietic cells or other normal tissues. Moreover, it is non-immunogenic, offering a safe strategy for killing CTCs, thereby reducing cancer relapse and improving clinical outcome.

Objective

This project XtraUS focuses on the prevention of cancer relapse and on the achievement of an early cure of recurrence, thus having a heavy impact on health and on its financial implications. Actually, many patients unfortunately get into a recurrence of their primary tumor disease, since their cancer is not fully remitted and they require further treatment to manage it. Minimal residual disease (MRD) after potentially curative treatment generally contributes to disease relapse and is the target of early adjuvant treatments. In particular, circulating tumor cells (CTCs) in the blood stream have a key role in cancer progression, recurrence and metastasis spreading. However, their such tiny amount is difficult to detect by conventional laboratory tests. From a social and financial perspective, fighting these cancer cells has a huge impact on cancer relapse prevention and thus on the health, quality of life and overall cancer treatment expenditure.
XtraUS aims at validating a breakthrough technology to fight CTCs in the bloodstream and thus reduces the rise of MRD and further cancer relapse. It applies an extracorporeal blood circulation set-up exploiting a novel stimuli-responsive, targeted and non-immunogenic nanoconstruct, remotely activated against CTCs. XtraUS results in a personalized and translational approach, with high-target specificity and reduced collateral damage to both blood and adjacent healthy tissues. With this technology, we aim to advance the conventional treatments of CTCs in the blood stream, proposing a more effective and safer treatment to fight cancer relapse and metastasis spreading than the current ones. The driving idea is to render permanent and efficacious the first treatment offered to patients for their primary tumor disease, avoid cancer relapse, and reduce all associated costs.
XtraUS is a versatile technology, with potential applications also on many other diseases, with huge societal and economic impacts on public health.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

ERC-POC - Proof of Concept Grant

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2020-PoC

See all projects funded under this call

Host institution

POLITECNICO DI TORINO
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 150 000,00
Address
CORSO DUCA DEGLI ABRUZZI 24
10129 Torino
Italy

See on map

Region
Nord-Ovest Piemonte Torino
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Beneficiaries (1)

My booklet 0 0